BIOGEN INC (IDP.DE) Stock Fundamental Analysis
FRA:IDP - Deutsche Boerse Ag - US09062X1037 - Common Stock - Currency: EUR
IDP gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 73 industry peers in the Biotechnology industry. While IDP belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. IDP is valued quite cheap, but it does not seem to be growing. These ratings could make IDP a good candidate for value investing.
1. Profitability
1.1 Basic Checks
IDP had positive earnings in the past year.
In the past year IDP had a positive cash flow from operations.
Each year in the past 5 years IDP has been profitable.
Each year in the past 5 years IDP had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 5.28%, IDP belongs to the best of the industry, outperforming 83.56% of the companies in the same industry.
Looking at the Return On Equity, with a value of 8.71%, IDP belongs to the top of the industry, outperforming 83.56% of the companies in the same industry.
IDP has a Return On Invested Capital of 9.95%. This is amongst the best in the industry. IDP outperforms 89.04% of its industry peers.
The Average Return On Invested Capital over the past 3 years for IDP is in line with the industry average of 11.99%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.28% | ||
| ROE | 8.71% | ||
| ROIC | 9.95% |
ROA(3y)7.52%
ROA(5y)9.06%
ROE(3y)13.45%
ROE(5y)18.41%
ROIC(3y)10.57%
ROIC(5y)13.65%
1.3 Margins
IDP's Profit Margin of 15.07% is amongst the best of the industry. IDP outperforms 84.93% of its industry peers.
In the last couple of years the Profit Margin of IDP has declined.
Looking at the Operating Margin, with a value of 26.30%, IDP belongs to the top of the industry, outperforming 89.04% of the companies in the same industry.
IDP's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 75.58%, IDP is in the better half of the industry, outperforming 71.23% of the companies in the same industry.
In the last couple of years the Gross Margin of IDP has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.3% | ||
| PM (TTM) | 15.07% | ||
| GM | 75.58% |
OM growth 3Y-4.87%
OM growth 5Y-12.22%
PM growth 3Y5.99%
PM growth 5Y-16.26%
GM growth 3Y-1.51%
GM growth 5Y-2.23%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IDP is destroying value.
The number of shares outstanding for IDP has been increased compared to 1 year ago.
Compared to 5 years ago, IDP has less shares outstanding
IDP has a better debt/assets ratio than last year.
2.2 Solvency
IDP has an Altman-Z score of 2.75. This is not the best score and indicates that IDP is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.75, IDP is in the better half of the industry, outperforming 71.23% of the companies in the same industry.
The Debt to FCF ratio of IDP is 2.74, which is a good value as it means it would take IDP, 2.74 years of fcf income to pay off all of its debts.
IDP has a Debt to FCF ratio of 2.74. This is amongst the best in the industry. IDP outperforms 87.67% of its industry peers.
A Debt/Equity ratio of 0.27 indicates that IDP is not too dependend on debt financing.
The Debt to Equity ratio of IDP (0.27) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 2.74 | ||
| Altman-Z | 2.75 |
ROIC/WACC0.94
WACC10.59%
2.3 Liquidity
IDP has a Current Ratio of 1.44. This is a normal value and indicates that IDP is financially healthy and should not expect problems in meeting its short term obligations.
IDP has a worse Current ratio (1.44) than 64.38% of its industry peers.
A Quick Ratio of 1.01 indicates that IDP should not have too much problems paying its short term obligations.
IDP has a worse Quick ratio (1.01) than 69.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.01 |
3. Growth
3.1 Past
IDP shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.61%.
Measured over the past years, IDP shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -13.31% on average per year.
IDP shows a decrease in Revenue. In the last year, the revenue decreased by -1.62%.
The Revenue has been decreasing by -7.62% on average over the past years.
EPS 1Y (TTM)-3.61%
EPS 3Y-4.95%
EPS 5Y-13.31%
EPS Q2Q%3.6%
Revenue 1Y (TTM)-1.62%
Revenue growth 3Y-4.13%
Revenue growth 5Y-7.62%
Sales Q2Q%7.33%
3.2 Future
The Earnings Per Share is expected to grow by 1.48% on average over the next years.
The Revenue is expected to decrease by -0.48% on average over the next years.
EPS Next Y-7.3%
EPS Next 2Y-2.23%
EPS Next 3Y0.32%
EPS Next 5Y1.48%
Revenue Next Year-3.89%
Revenue Next 2Y-2.99%
Revenue Next 3Y-1.68%
Revenue Next 5Y-0.48%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 7.99, the valuation of IDP can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of IDP indicates a rather cheap valuation: IDP is cheaper than 94.52% of the companies listed in the same industry.
IDP's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.48.
Based on the Price/Forward Earnings ratio of 8.12, the valuation of IDP can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IDP indicates a rather cheap valuation: IDP is cheaper than 98.63% of the companies listed in the same industry.
IDP's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 34.04.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.99 | ||
| Fwd PE | 8.12 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IDP is valued cheaper than 91.78% of the companies in the same industry.
IDP's Price/Free Cash Flow ratio is rather cheap when compared to the industry. IDP is cheaper than 94.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.16 | ||
| EV/EBITDA | 6.82 |
4.3 Compensation for Growth
IDP has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.23%
EPS Next 3Y0.32%
5. Dividend
5.1 Amount
IDP does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:IDP (8/8/2025, 7:00:00 PM)
109.85
-0.1 (-0.09%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners92.67%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap16.10B
Analysts72.09
Price Target148.87 (35.52%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.97%
Min EPS beat(2)0.67%
Max EPS beat(2)17.28%
EPS beat(4)4
Avg EPS beat(4)13.01%
Min EPS beat(4)0.67%
Max EPS beat(4)28.61%
EPS beat(8)8
Avg EPS beat(8)8.78%
EPS beat(12)12
Avg EPS beat(12)10.47%
EPS beat(16)14
Avg EPS beat(16)9.94%
Revenue beat(2)2
Avg Revenue beat(2)3.39%
Min Revenue beat(2)0.11%
Max Revenue beat(2)6.67%
Revenue beat(4)3
Avg Revenue beat(4)1.89%
Min Revenue beat(4)-0.68%
Max Revenue beat(4)6.67%
Revenue beat(8)5
Avg Revenue beat(8)0.61%
Revenue beat(12)8
Avg Revenue beat(12)1.03%
Revenue beat(16)11
Avg Revenue beat(16)1.28%
PT rev (1m)0.86%
PT rev (3m)-9.06%
EPS NQ rev (1m)-4.96%
EPS NQ rev (3m)-5.59%
EPS NY rev (1m)0.02%
EPS NY rev (3m)-5.08%
Revenue NQ rev (1m)0.21%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)0.44%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.99 | ||
| Fwd PE | 8.12 | ||
| P/S | 1.91 | ||
| P/FCF | 8.16 | ||
| P/OCF | 7.26 | ||
| P/B | 1.1 | ||
| P/tB | 20.44 | ||
| EV/EBITDA | 6.82 |
EPS(TTM)13.75
EY12.52%
EPS(NY)13.52
Fwd EY12.31%
FCF(TTM)13.46
FCFY12.25%
OCF(TTM)15.13
OCFY13.78%
SpS57.54
BVpS99.52
TBVpS5.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.28% | ||
| ROE | 8.71% | ||
| ROCE | 11.36% | ||
| ROIC | 9.95% | ||
| ROICexc | 11.23% | ||
| ROICexgc | 55.5% | ||
| OM | 26.3% | ||
| PM (TTM) | 15.07% | ||
| GM | 75.58% | ||
| FCFM | 23.39% |
ROA(3y)7.52%
ROA(5y)9.06%
ROE(3y)13.45%
ROE(5y)18.41%
ROIC(3y)10.57%
ROIC(5y)13.65%
ROICexc(3y)12.43%
ROICexc(5y)16.11%
ROICexgc(3y)38.35%
ROICexgc(5y)40.12%
ROCE(3y)12.07%
ROCE(5y)15.58%
ROICexcg growth 3Y14.15%
ROICexcg growth 5Y-5.35%
ROICexc growth 3Y-15.93%
ROICexc growth 5Y-20.8%
OM growth 3Y-4.87%
OM growth 5Y-12.22%
PM growth 3Y5.99%
PM growth 5Y-16.26%
GM growth 3Y-1.51%
GM growth 5Y-2.23%
F-Score6
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 2.74 | ||
| Debt/EBITDA | 1.38 | ||
| Cap/Depr | 40.34% | ||
| Cap/Sales | 2.91% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 78.44% | ||
| Profit Quality | 155.18% | ||
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.01 | ||
| Altman-Z | 2.75 |
F-Score6
WACC10.59%
ROIC/WACC0.94
Cap/Depr(3y)54.43%
Cap/Depr(5y)68.89%
Cap/Sales(3y)3.09%
Cap/Sales(5y)3.21%
Profit Quality(3y)99.34%
Profit Quality(5y)120.98%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.61%
EPS 3Y-4.95%
EPS 5Y-13.31%
EPS Q2Q%3.6%
EPS Next Y-7.3%
EPS Next 2Y-2.23%
EPS Next 3Y0.32%
EPS Next 5Y1.48%
Revenue 1Y (TTM)-1.62%
Revenue growth 3Y-4.13%
Revenue growth 5Y-7.62%
Sales Q2Q%7.33%
Revenue Next Year-3.89%
Revenue Next 2Y-2.99%
Revenue Next 3Y-1.68%
Revenue Next 5Y-0.48%
EBIT growth 1Y21.69%
EBIT growth 3Y-8.8%
EBIT growth 5Y-18.9%
EBIT Next Year9.62%
EBIT Next 3Y4.45%
EBIT Next 5Y5.34%
FCF growth 1Y61.56%
FCF growth 3Y-9.06%
FCF growth 5Y-17.06%
OCF growth 1Y53.87%
OCF growth 3Y-7.56%
OCF growth 5Y-16.49%